HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Assesment of selected parameters depending on the size of abdominal wall incision in patients subjected to minilaparotomy due to benign gynaecological diseases].

AbstractOBJECTIVES:
Considering the enormous advantages of minimally invasive surgery, attempts to introduce less invasive trans-abdominal incisions might represent an alternative to classic gynecologic surgery. The aim of this study is to assess the feasibility and clinical outcome of minilaparotomy in patients operated due to benign gynecological diseases and to analyze selected parameters with regard to the abdominal wall incision size.
DESIGN:
In this retrospective study, we have described our experience with 26 patients, undergoing minilaparotomy for benign adnexal or uterine diseases.
MATERIAL AND METHODS:
26 patients with benign uterine or adnexal diseases, hospitalized from November 2003 until March 2006 at the Department of Surgical and Endoscopic Gynecology at the Polish Mother's Memorial Hospital--Research Institute in Lódź, had undergone successful surgical treatment by means of minilaparotomy. The following procedures were included in the analysis: myomectomy (17 patients), ovarian cystectomy (3 patients), myomectomy and ovarian cystectomy at the same time (3 patients), bilateral salpingo-oophorectomy (1 patient), supracervical hysterectomy (1 patient) and total abdominal hysterectomy with salpingo--oophorectomy (1 patient).
RESULTS:
The patients' mean age and BMI were 33.85 years (14-50) and 22.95 (18.73-45.17), respectively. The mean operative time was 72.69 min (45-120). The diameter of trans-abdominal incision was 3-6cm and the mean diameter of removed lesions was 76.88 mm (47-200). The mean intraoperative decrease of haematocrit and haemoglobin value was 4.8% (0.2-12.4) and 1.4 g/dl (0.2-3.7), respectively. Blood transfusion was required in case of 3 patients but only in one case it was caused by intraoperative blood loss. There were no significant intra- or postoperative complications. 16 patients needed analgesics for 2.33 days after surgery. Body temperature up to 38 degrees C was observed in 4 patients for 2.5 days. The average time of hospitalization after the surgery was 4.58 days. We have noted a negative correlation between the size of trans-abdominal incision and several factors: operative time, intraoperative blood loss, period of analgesic therapy and time of hospitalization after the surgery. None of these factors was correlated with patients' age or BMI. One-month follow up after the surgery revealed satisfactory wound healing and no complains in case of all patients. All patients deemed the cosmetic effect of the surgery very good.
CONCLUSION:
Minilaparotomy seems to be a very simple, useful and safe surgical technique which might be an alternative to laparotomy in the management of benign gynecologic diseases. Minilaparotomy is of great value, especially in situations when laparoscopic or vaginal approach is too complicated or too dangerous due to technical reasons.
AuthorsAndrzej Malinowski, Artur Matyszewski, Ilona Bartosiak-Majcher, Michał Wojciechowski
JournalGinekologia polska (Ginekol Pol) Vol. 79 Issue 3 Pg. 192-7 (Mar 2008) ISSN: 0017-0011 [Print] Poland
Vernacular TitleOcena wybranych parametrów w zalezności od długości nacieccia powłok brzusznych u pacjentek poddanych minilaparotomii z powodu niezłośliwych zmian w obrebie narzadów płciowych.
PMID18592854 (Publication Type: English Abstract, Journal Article)
Topics
  • Adnexal Diseases (surgery)
  • Adolescent
  • Adult
  • Blood Loss, Surgical (prevention & control)
  • Fallopian Tubes (surgery)
  • Feasibility Studies
  • Female
  • Humans
  • Hysterectomy (methods)
  • Laparotomy (instrumentation, methods)
  • Leiomyoma (surgery)
  • Middle Aged
  • Minimally Invasive Surgical Procedures (methods)
  • Poland
  • Postoperative Complications (prevention & control)
  • Retrospective Studies
  • Uterine Diseases (surgery)
  • Uterine Neoplasms (surgery)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: